Paper42967142PubMed
A Practical Update on Percutaneous Coronary Intervention (PCI) for the General Physician, Answering Questions of Patient Type, Timing, and Device Choice.
Ong HT and 3 others. Int J Gen Med, 2026.
Cite this record
ConductScience Library. A Practical Update on Percutaneous Coronary Intervention (PCI) for the General Physician, Answering Questions of Patient Type, Timing, and Device Choice. Papers, record 42967142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42967142
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Practical Update on Percutaneous Coronary Intervention (PCI) for the General Physician, Answering Questions of Patient Type, Timing, and Device Choice.
- Journal
- Int J Gen Med
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-11-02
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References117
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27933192 | Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction. | Open Heart | 2016 | https://conductscience.org/library/papers/27933192 | PubMed |
| 2 | 37326377 | Bioresorbable coronary scaffolds are ready for a comeback: pros and cons. | EuroIntervention | 2023 | https://conductscience.org/library/papers/37326377 | PubMed |
| 3 | 30428398 | Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study. | J Am Coll Cardiol | 2019 | https://conductscience.org/library/papers/30428398 | PubMed |
| 4 | 34514494 | Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial. | Eur Heart J | 2022 | https://conductscience.org/library/papers/34514494 | PubMed |
| 5 | 25596468 | Early invasive strategy in high-risk acute coronary syndrome without ST-segment elevation. The Sisca randomized trial. | Int J Cardiol | 2015 | https://conductscience.org/library/papers/25596468 | PubMed |
| 6 | 10468519 | Process of progression of coronary artery lesions from mild or moderate stenosis to moderate or severe stenosis: A study based on four serial coronary arteriograms per year. | Circulation | 1999 | https://conductscience.org/library/papers/10468519 | PubMed |
| 7 | 29083953 | PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. | N Engl J Med | 2017 | https://conductscience.org/library/papers/29083953 | PubMed |
| 8 | 32227753 | Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32227753 | PubMed |
| 9 | 30819365 | PCI and CABG for Treating Stable Coronary Artery Disease: JACC Review Topic of the Week. | J Am Coll Cardiol | 2019 | https://conductscience.org/library/papers/30819365 | PubMed |
| 10 | 36807512 | Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial. | Eur Heart J | 2023 | https://conductscience.org/library/papers/36807512 | PubMed |
| 11 | 26334160 | Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis. | Lancet | 2015 | https://conductscience.org/library/papers/26334160 | PubMed |
| 12 | 36386315 | Bioresorbable scaffolds vs. drug-eluting stents for patients with myocardial infarction: A systematic review and meta-analysis of randomized clinical trials. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/36386315 | PubMed |
| 13 | 12517460 | Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. | Lancet | 2003 | https://conductscience.org/library/papers/12517460 | PubMed |
| 14 | 8837556 | Results of coronary stenting for restenosis. | J Am Coll Cardiol | 1996 | https://conductscience.org/library/papers/8837556 | PubMed |
| 15 | 12930925 | A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. | N Engl J Med | 2003 | https://conductscience.org/library/papers/12930925 | PubMed |
| 16 | 19502645 | A randomized trial of therapies for type 2 diabetes and coronary artery disease. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19502645 | PubMed |
| 17 | 33663733 | 10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction. | J Am Coll Cardiol | 2021 | https://conductscience.org/library/papers/33663733 | PubMed |
| 18 | 38286514 | Percutaneous coronary intervention versus medical therapy in stable angina: a matched cohort study. | Heart | 2024 | https://conductscience.org/library/papers/38286514 | PubMed |
| 19 | 26559572 | Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease. | N Engl J Med | 2015 | https://conductscience.org/library/papers/26559572 | PubMed |
| 20 | 36846695 | Evaluation of coronary stents: A review of types, materials, processing techniques, design, and problems. | Heliyon | 2023 | https://conductscience.org/library/papers/36846695 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42967142
GET https://conductscience.org/api/papers/v1/42967142/references?page=2